Related Experiment Video
Updated: Nov 10, 2025

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
Assessment of COVID-19 deaths from cardiological perspective
Timor Omar1, Muammer Karakayalı1, Gökhan Perincek2
1Department of Cardiology, M.D. Kars Harakani State Hospital, Kars, Turkey.
Insights
COVID-19 cardiac injury, indicated by elevated high-sensitivity troponin T (hs-TnT) and ECG abnormalities, significantly increases in-hospital mortality risk. Early identification and aggressive treatment are crucial for high-risk patients.
Area of Science:
- Cardiology
- Infectious Diseases
- Internal Medicine
Background:
- COVID-19 is associated with diverse cardiac complications and electrocardiographic (ECG) abnormalities.
- Assessing cardiological parameters is vital for understanding COVID-19 patient outcomes.
Purpose of the Study:
- To analyze cardiological parameters, including ECG and high-sensitivity troponin T (hs-TnT), in hospitalized COVID-19 patients.
- To determine the association between these parameters and in-hospital mortality.
Main Methods:
- Retrospective analysis of 453 hospitalized COVID-19 patients with known outcomes.
- Comparison of demographic, comorbidity, laboratory, and ECG findings between survivors and non-survivors, and between cardiac injury and no-cardiac injury subgroups.
Main Results:
- Cardiac injury was linked to significantly higher in-hospital mortality.
- Patients with cardiac injury showed increased frequencies of atrial fibrillation, axis change, ST-segment/T-wave changes, fragmented QRS, and premature contractions.
- Non-survivors exhibited longer QRS intervals, more frequent ST-segment/T-wave changes, and an isolated S1Q3T3 pattern. Elevated hs-TnT levels at admission were markedly higher in non-survivors.
- hs-TnT, age, and respiratory rate were independent predictors of mortality. Comorbidities were more prevalent in non-survivors and the cardiac injury group.
Conclusions:
- Elevated hs-TnT and ECG abnormalities indicating cardiac involvement on admission predict poor prognosis and increased in-hospital mortality in COVID-19 patients.
- Prioritized and aggressive therapeutic strategies are recommended for these high-risk patients to reduce mortality.
Background:
COVID-19 can cause a variety of cardiac complications and a range of electrocardiographic abnormalities. We analysed cardiological parameters including ECG and high-sensitivity troponin T (hs-TnT) level and their association with mortality in hospitalised patients with COVID-19.
Methods:
We retrospectively analysed the demographics, comorbidities, laboratory findings and electrocardiographic parameters of 453 consecutive patients, whose outcome was clear, died or discharged. Findings were compared between survivors and non-survivors. Also, the same comparison was made between cardiac injury and no-cardiac injury subgroups.
Results:
The cardiac injury group had significantly higher in-hospital mortality than the no-cardiac injury group. Also, frequencies of atrial fibrillation, axis change, ST-segment/T-wave change, fragmented QRS, premature atrial/ventricular contraction was found to be higher in the cardiac injury group. Moreover, non-survivors had longer QRS intervals, more frequent ST-segment/T-wave changes and isolated S1Q3T3 pattern than surviving patients. Laboratory results showed median values of hs-TnT at the admission of 4.95 ng/L (IQR, 3-12.35) with concentrations markedly higher in the non-surviving patients vs survivors. Hs-TnT value along with age and respiratory rate was found to be an independent predictor of in-hospital mortality in hospitalised patients with COVID-19. Comorbidities were more frequently reported in non-surviving and cardiac injury groups than those surviving and without cardiac injury.
Conclusions:
In COVID-19 patients, both elevated hs-TnT and ECG abnormalities, suggesting cardiac involvement, on admission portends an ominous prognosis and indicates at higher risk of in-hospital mortality. Prioritised treatment and more aggressive therapeutic strategies could be planned to avoid the occurrence of death in these patients.
More Related Videos
18:11A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
Published on: December 28, 2012
07:51Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
Related Concept Videos
Coronary Artery Disease III: Clinical Manifestations
Cardiomyopathy II: Dilated Cardiomyopathy
Introduction Cardiac Emergencies
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Acute Coronary Syndrome III: Diagnostic Studies